Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
Clinical trial NCT03932409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03932409
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2025-09-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.